In the wake of the Paris terror attacks, President Obama has earned his worst rating on his handling of terrorism in his career.
Currently, 54 percent of U.S. adults disapprove of the way in which Obama is handling terrorism threats, the worst such rating in his White House career, according to an ABC News/Washington Post poll released Friday. Forty-three percent of Americans disapprove strongly of the president’s handling of terror threats.
Americans are particularly critical of Obama’s response to the Islamic State (IS, also known as ISIL or ISIS), the terrorist group that claimed responsibility for the deadly attacks in Paris and that has also threatened attacks on the United States. Fifty-seven percent of U.S. adults disapprove of Obama’s handling of IS, with 46 percent doing so strongly.
General Electric (GE.N) won U.S. antitrust approval to buy Alstom’s also.pa power unit with conditions, the Justice Department said on Tuesday.
To complete the 12.4-billion-euro ($13.9 billion) deal, GE will be required to sell an Alstom subsidiary which provides aftermarket parts and services, the department said.
The deal also won antitrust approval in Europe on Tuesday.
The new solution for women lacking their libido, or sexual desire, is called flibanserin and will now be administered under the strictest of guidelines.
Created by Sprout Pharmaceuticals under the brand name Addyi, the drug received FDA approval with certain limitations. The healthcare watchdog is now requiring trained doctors and pharmacists to keep track of any problems associated with the daily use of the “female Viagra.”
“This is the biggest breakthrough in women’s sexual health since the advent of ‘the Pill’” for contraception, The National Consumers League said in a statement. “It validates (and) legitimizes female sexuality as an important component of health.”